Ardelyx, Inc. (ARDX)
NASDAQ: ARDX · IEX Real-Time Price · USD
6.29
-0.06 (-0.94%)
At close: Jun 17, 2024, 4:00 PM
6.28
-0.01 (-0.16%)
After-hours: Jun 17, 2024, 5:31 PM EDT

Ardelyx Revenue

Ardelyx had revenue of $159.11M in the twelve months ending March 31, 2024, with 152.32% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $46.02M with 304.81% year-over-year growth. In the year 2023, Ardelyx had annual revenue of $124.46M with 138.61% growth.

Revenue (ttm)
$159.11M
Revenue Growth
+152.32%
P/S Ratio
9.35
Revenue / Employee
$595,918
Employees
267
Market Cap
1.47B USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023124.46M72.30M138.61%
Dec 31, 202252.16M42.06M416.57%
Dec 31, 202110.10M2.53M33.36%
Dec 31, 20207.57M2.29M43.36%
Dec 31, 20195.28M2.67M102.57%
Dec 31, 20182.61M-39.39M-93.79%
Dec 31, 201742.00M--
Dec 31, 20160--
Dec 31, 201524.03M-7.60M-24.02%
Dec 31, 201431.62M2.70M9.32%
Dec 31, 201328.93M23.52M434.71%
Dec 31, 20125.41M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
AdaptHealth 3.25B
Tilray Brands 743.25M
U.S. Physical Therapy 611.97M
Supernus Pharmaceuticals 597.40M
Alphatec Holdings 511.63M
Dynavax Technologies 236.15M
Schrödinger 188.48M
Ligand Pharmaceuticals 118.31M
Revenue Rankings